Jiangsu Sinopep-Allsino Biopharmaceutical (SH:688076) Zhi Tong Cai Jing·2026-02-03 10:29Core Viewpoint - ST诺泰's subsidiary, Hangzhou Ausino Biotechnology Co., Ltd., has successfully passed the GMP compliance inspection for its active pharmaceutical ingredient, Aogetwei Sodium, marking a significant milestone in its production capabilities [1] Group 1: Company Achievements - The company received the GMP compliance inspection notice from the Zhejiang Provincial Drug Administration, indicating its adherence to high production and quality management standards [1] - The successful inspection of the raw material production line at the Jiande factory reinforces the company's commitment to leading in both time and technology [1] Group 2: Business Implications - This achievement is pivotal for the company's CDMO (Contract Development and Manufacturing Organization) business, allowing it to extend its value from advanced intermediates to active pharmaceutical ingredients [1] - The milestone is expected to positively impact the company's efforts in expanding its client base for innovative pharmaceutical raw materials [1]